Sabin Receives Additional $21.8 Million From BARDA to Advance Marburg Vaccine

WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. These funds advance development […]

Continue Reading

Sabin reçoit 21,8 millions de dollars supplémentaires de la part de la BARDA pour faire progresser le vaccin contre le virus Marburg

WASHINGTON, 14 sept. 2022 (GLOBE NEWSWIRE) —  Le Sabin Vaccine Institute a annoncé aujourd’hui avoir reçu 21,8 millions de dollars supplémentaires dans le cadre d’un contrat existant avec la Biomedical Advanced Research and Development Authority (BARDA), qui fait partie de l’Administration pour la préparation et la réponse stratégiques du Département de la Santé et des Services […]

Continue Reading

Sabin recebe US $ 21,8 milhões adicionais da BARDA para o desenvolvimento da Vacina Marburg

WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) — O Sabin Vaccine Institute anunciou hoje o recebimento de US $ 21,8 milhões adicionais sob um contrato existente com a Biomedical Advanced Research and Development Authority (BARDA), parte da Administração de Preparação e Resposta Estratégica do Departamento de Saúde e Serviços Humanos dos EUA. Esses fundos visam promover […]

Continue Reading